Rifampin isoniazid

Revision as of 04:26, 4 January 2014 by Chetan Lokhande (talk | contribs) (Created page with " __NOTOC__ {{Rifampin isoniazid}} {{CMG}}; {{AE}} {{chetan}} ==Overview== ==Category== ==US Brand Names== ==FDA Package Insert== '''Rifampin isoniazid description|Descri...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Rifampin isoniazid
FDA Package Insert (RIFAMATE®)
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Overview

Category

US Brand Names

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages

Mechanisms of Action

References

Retrieved from "https://www.wikidoc.org/index.php?title=Rifampin_isoniazid&oldid=924007"